Lhasa Limited shared knowledge shared progress

Sarah Features and Benefits

Sarah Nexus has various features and benefits. To find out more about how Sarah Nexus can help you, please get in touch.

Sarah icons 05 55px

Expert ICH M7 Support

Sarah predictions are accepted by regulators under the ICH M7 guideline. The M7 functionality allows for simultaneous compound processing in Sarah and Derek against the mutagenicity in vitro endpoint, fulfilling both the expert rule-based and statistical-based predictions required under ICH M7.

Sarah icons 01 55px

Rapid Mutagenicity Assessment

Sarah can swiftly provide single or batch predictions for the mutagenicity of query compounds.

Sarah icons 03 55px

Extensive Coverage of Chemical Space

“Out of Domain” predictions are of little value when conducting expert review and add additional complexity to this process. Sarah’s large, high-quality training set ensures maximum coverage of chemical space thus minimising problematic “Out of Domains”.

Sarah icons 02 55px

Accurate Predictions for Proprietary Compounds

Sarah has been extensively evaluated using pharmaceutical proprietary data sets and delivers high performance (Barber et al. 2015).

Sarah icons 11 55px

Confident Predictions

The Sarah model is built upon a large, high-quality dataset that has been curated by Lhasa experts. Structures have been standardised and conflicting data points have been solidly assessed meaning you can be confident that the predictions are based on scientifically robust data.

Sarah icons 07 55px

Transparent Predictions

Predictions are clearly represented and supported by a measure of confidence, the fragments on which the predictions are based and relevant examples from the Sarah training set ordered by structural similarity to the query compound. This high level of transparency facilitates the expert review process.

Sarah icons 10 55px

Wealth of Supporting Information

In order to aid expert review, Sarah incorporates additional data such as strain information, similar compounds which were not included in the model, and references. This additional information is available for single predictions, batch predictions, and batch validations.

Sarah icons 12 55px

User Control

Sarah has default prediction settings that have been designed to ensure the best balance between sensitivity and specificity for use under the ICH M7 guideline. However, it is recognised that users may want to change this approach for their particular need and Sarah’s intuitive prediction setup options allow you to tailor the prediction accordingly.

Sarah icons 06 55px

One Interface, Multiple Predictions

Using Sarah within the Nexus platform can give you direct access to other Lhasa in silico tools, including Meteor NexusDerek Nexus and Vitic, improving workflow efficiency.

Sarah icons 09 55px

Customisable Reports

Sarah incorporates a reporting framework that allows (.doc .pdf .xlsx and .sdf) file export. Report templates are fully customisable by the end user ensuring that you can provide the right information at the right time.

Sarah icons 10 55px

Auto Classification

A user-editable classification is derived from the predictions provided by Derek, Sarah and any relevant experimental information included.

Barber et al. (2015). ‘Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained’, Regulatory Toxicology and Pharmacology, vol. 76, April, p. 7-20. http://dx.doi.org/10.1016/j.yrtph.2015.12.006

© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).